PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue
Nov 21, 2022
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (“RA”), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue, with initial data expected during the first quarter of 2023. “SPU-21 was shown to inhibit arthritic progression in a preclinical animal model, so we are proceeding to advance our research into human synovial tissue, where we will first assess binding affinity,” said Eric Weisblum, CEO of Silo Pharma. “Positive data from this important study could support further research into the interaction of our joint homing peptide as a potential therapy for autoimmune disorders such as rheumatoid arthritis and inflammation. We look forward to progressing our development of SPU-21 through our valued collaboration with the University of Maryland, Baltimore.”
To view the full press release, visit https://ibn.fm/fKPlY
About Silo Pharma Inc.
Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
What food items should you stock up on in case of an emergency?
Extreme weather may be changing the way we need to shop, with the UK government urging people to stock up on canned goods.
A Borrower’s Timeline of the Public Service Loan Forgiveness Quagmire
One county lawyer’s repayment saga stretches nearly 20 years, though she’s tried 22 times over the past 20 months to erase her debt.
Ed Davey calls for immediate 10p cut to fuel duty
Sir Ed blamed Donald Trump's war with Iran for damaging the UK economy and pushing fuel prices up.
Uber to Pay $40 Million to Parents of Woman Fatally Hit by Car
Emily Normandin-Parker, 23, was struck and killed on a California freeway after an Uber driver ordered her and a friend out of his car in August 2023.
BizDataDive: How fresh produce connects two agricultural powerhouses
China-US farm trade hit $14.1 billion in the first half of 2026 — that's around $78 million worth agricultural produce crossing the Pacific every day. From American soybeans in China's soy milk to Chinese garlic on US supermarket shelves, one table feeds two nations.
Lib Dems vow to end 'computer says no' economy to boost growth
Deputy leader Daisy Cooper also proposes a Growth and Defence Partnership with the EU in a speech to her party conference.
BizDataDive: Why does a new drug require joint R&D?
In this episode, we explore why drug development knows no borders.
Explainer: Where do China-US economic and trade ties stand?
Chinese Vice Premier He Lifeng is leading a delegation to the United States for economic and trade consultations with the US side from September 19 to 23.
Billionaire Man United owner loses moral high ground after tax exile, Labour chair says
The billionaire businessman told the BBC he has lost confidence in the UK due to a combination of high taxes and high immigration.
US debt, physical constraints, and the restructuring of global capital
Global monetary tightening, energy supply disruptions and trade policy changes are creating structural cost pressures and capital reallocations across the global economy. These pressures are accelerating shifts toward local-currency financing, alternative debt markets and industrial transformation, particularly across emerging economies.
What to Do If You’re Laid Off and Too Young for Medicare
At best, older, laid-off workers will struggle to find health insurance that bridges the years before they qualify for Medicare at age 65.
Chiltern Railways renationalised after 30 years
It joins Great British Railways as part of government plans to save money and improve services.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.